Abstract

BACKGROUND CONTEXT Contained lumbar disc herniations frequently cause back- and leg pain. Clinical outcomes with surgical treatment may be affected by the size and location of the disc herniation. The surgical directly visualized transforaminal endoscopic decompression has gained acceptance and popularity, while the simplified percutaneous laser disc decompression has fallen out of favor in spite of its initial success as a minimally invasive intervention. In an attempt to better understand the durability of both procedures, the authors performed a comparative analysis of clinical outcomes in patients with contained lumbar disc herniations. PURPOSE In an attempt to better understand the durability of both procedures, the authors performed a comparative analysis of clinical outcomes in patients with contained lumbar disc herniations. STUDY DESIGN/SETTING This retrospective study selected from groups of consecutive patients seen in clinics of the participating study sites. PATIENT SAMPLE The study population consisted of 248 patients consisting of 162 patients in the endoscopy group (group 1) and 86 patients in the laser group (group 2). OUTCOME MEASURES Primary outcome measures were Macnab criteria. METHODS Herniations were classified as large or small. Additional parameters of advanced degeneration of the lumbar motion segment including posterior disc- and lateral recess height of RESULTS The mean follow-up was 43.5 months. The serial time recorded for Kaplan-Meier analysis ranged from 1.5 to 84 months. The mean age was 53.4 years (standard deviation=14.65 years). The majority of patients had excellent and good Macnab outcomes (212/248; 85.5%) regardless of treatment. Fair and poor results were achieved in another 36 patients (14.5%). There was a higher percentage of excellent Macnab outcomes in the endoscopy group (94/162; 58.0%) than in the laser group (38/86; 44.2%) at a statistically significant level (P CONCLUSIONS Transforaminal endoscopic decompression for symptomatic herniated disc is an effective and durable surgical treatment to alleviate sciatica-type and back symptoms in the vast majority of patients with good long-term survival of pain relief for up to 6 years. Interventional percutaneous nonvisualized laser decompression for the same condition may provide favorable outcomes in the short-term with soft protrusions. However, the treatment effect deteriorates much faster with a median survival of 17 months. FDA DEVICE/DRUG STATUS This abstract does not discuss or include any applicable devices or drugs.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call